Effect of Palivizumab Treatment on Subsequent Recurrent Wheezing in Preterm Infants: Case-control Study by Scientific Committee of Recurrent Wheezing (SCREW).
Phase of Trial: Phase IV
Latest Information Update: 14 Oct 2013
At a glance
- Drugs Palivizumab (Primary)
- Indications Allergic asthma; Respiratory syncytial virus infections
- Focus Therapeutic Use
- 02 Apr 2012 Actual patient number (444) added as reported by ClinicalTrials.gov.
- 02 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2012 Actual end date (1 Aug 2011) added as reported by ClinicalTrials.gov.